These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22550511)

  • 41. Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts.
    Bang JS; Choi NY; Lee M; Ko K; Lee HJ; Park YS; Jeong D; Chung HM; Ko K
    Anim Cells Syst (Seoul); 2018; 22(2):132-139. PubMed ID: 30460090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An ECM-based culture system for the generation and maintenance of xeno-free human iPS cells.
    Kim HT; Lee KI; Kim DW; Hwang DY
    Biomaterials; 2013 Jan; 34(4):1041-50. PubMed ID: 23153417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Derivation of Induced Pluripotent Stem Cells from Human Fibroblasts Using a Non-integrative System in Feeder-free Conditions.
    Beltran AA; Molina SG; Beltran AS
    Bio Protoc; 2020 Oct; 10(20):e3788. PubMed ID: 33659443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of pluripotent stem cells by reprogramming human ocular fibroblasts under xeno-free conditions.
    Xiong Y; Liu Y; Ge J
    Arq Bras Oftalmol; 2018; 81(5):376-383. PubMed ID: 30208139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Robust production of human neural cells by establishing neuroepithelial-like stem cells from peripheral blood mononuclear cell-derived feeder-free iPSCs under xeno-free conditions.
    Isoda M; Kohyama J; Iwanami A; Sanosaka T; Sugai K; Yamaguchi R; Matsumoto T; Nakamura M; Okano H
    Neurosci Res; 2016 Sep; 110():18-28. PubMed ID: 27083781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
    Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
    Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.
    Chou BK; Gu H; Gao Y; Dowey SN; Wang Y; Shi J; Li Y; Ye Z; Cheng T; Cheng L
    Stem Cells Transl Med; 2015 Apr; 4(4):320-32. PubMed ID: 25742692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system.
    Lai WH; Ho JC; Lee YK; Ng KM; Au KW; Chan YC; Lau CP; Tse HF; Siu CW
    Cell Reprogram; 2010 Dec; 12(6):641-53. PubMed ID: 20858051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Creation of GMP-Compliant iPSCs From Banked Umbilical Cord Blood.
    Tian P; Elefanty A; Stanley EG; Durnall JC; Thompson LH; Elwood NJ
    Front Cell Dev Biol; 2022; 10():835321. PubMed ID: 35372371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of induced pluripotent stem cells from human amniotic fluid cells by reprogramming with two factors in feeder-free conditions.
    Li Q; Fan Y; Sun X; Yu Y
    J Reprod Dev; 2013; 59(1):72-7. PubMed ID: 23138118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes.
    Tan X; Dai Q; Guo T; Xu J; Dai Q
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2490-2497. PubMed ID: 29217199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of Human Induced Pluripotent Stem Cells Using a Defined, Feeder-Free Reprogramming System.
    Park S; Mostoslavsky G
    Curr Protoc Stem Cell Biol; 2018 May; 45(1):e48. PubMed ID: 30040234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishment of transgene-free induced pluripotent stem cells reprogrammed from human stem cells of apical papilla for neural differentiation.
    Zou XY; Yang HY; Yu Z; Tan XB; Yan X; Huang GT
    Stem Cell Res Ther; 2012 Oct; 3(5):43. PubMed ID: 23095454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.
    Merling RK; Sweeney CL; Choi U; De Ravin SS; Myers TG; Otaizo-Carrasquero F; Pan J; Linton G; Chen L; Koontz S; Theobald NL; Malech HL
    Blood; 2013 Apr; 121(14):e98-107. PubMed ID: 23386128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
    Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
    J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.
    Sommer CA; Christodoulou C; Gianotti-Sommer A; Shen SS; Sailaja BS; Hezroni H; Spira A; Meshorer E; Kotton DN; Mostoslavsky G
    PLoS One; 2012; 7(12):e51711. PubMed ID: 23272148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic mRNA Reprogramming of Human Fibroblast Cells.
    Liu J; Verma PJ
    Methods Mol Biol; 2015; 1330():17-28. PubMed ID: 26621585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient feeder-free episomal reprogramming with small molecules.
    Yu J; Chau KF; Vodyanik MA; Jiang J; Jiang Y
    PLoS One; 2011 Mar; 6(3):e17557. PubMed ID: 21390254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.